EGT0001474

DRUG2 trials

Sponsors

Theracos

Conditions

Diabetes Mellitus Type 2Safety and Tolerability of EGT0001474 in Healthy Volunteers

Phase 1

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

CompletedNCT00854113

TheracosSafety and Tolerability of EGT0001474 in Healthy Volunteers

Start: 2009-02-28End: 2009-07-31Updated: 2019-06-06

Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes

CompletedNCT00924053

TheracosDiabetes Mellitus Type 2

Start: 2009-06-30End: 2009-07-31Updated: 2019-06-17